Oliver Ebert
Impact in
- Genetics top 2%
- Virus-based gene therapy research
- Hepatology top 5%
- Hepatocellular Carcinoma Treatment and Prognosis
Papers in
- Genetics 37
- Virus-based gene therapy research 37
-
- Hepatocellular Carcinoma Treatment and Prognosis 4
- Co-authors
- Savio L.C. Woo (14 shared papers)Katsunori Shinozaki (10 shared papers)Jennifer Altomonte (22 shared papers)Adolfo García‐Sastre (6 shared papers)Roland Michael Schmid (12 shared papers)Sabrina Marozin (7 shared papers)Chryssanthi S. Kournioti (2 shared papers)Tiangui Huang (3 shared papers)
- Journals
- Molecular Therapy (7 papers)Cancer Gene Therapy (5 papers)Journal of Virology (4 papers)Journal of Hepatology (2 papers)Hepatology (2 papers)
- Partner nations
- GermanyUnited StatesJapan
In The Last Decade
Oliver Ebert
48 papers receiving 1.8k citations
Peers
Comparison fields: 5 of 71
- Genetics 1.1k
- Hepatology 214
- Immunology 261
- Oncology 146
- Biotechnology 29
Countries citing papers authored by Oliver Ebert
This map shows the geographic impact of Oliver Ebert's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Oliver Ebert with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Oliver Ebert more than expected).
Fields of papers citing papers by Oliver Ebert
This network shows the impact of papers produced by Oliver Ebert. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Oliver Ebert. The network helps show where Oliver Ebert may publish in the future.
Co-authors
The 25 scholars most cited alongside Oliver Ebert, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 48 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2016 | 118 | |
| 2 | 2019 | 115 | |
| 3 | Oncolytic vesicular stomatitis virus for treatment of orthotopic hepatocellular carcinoma in immune-competent rats. | 2003 | 104 |
| 4 | 2004 | 99 | |
| 5 | 2004 | 84 | |
| 6 | 2011 | 82 | |
| 7 | 2004 | 77 | |
| 8 | 2009 | 77 | |
| 9 | 2007 | 67 | |
| 10 | 2008 | 64 | |
| 11 | 2007 | 63 | |
| 12 | 1998 | 61 | |
| 13 | 2008 | 58 | |
| 14 | 2018 | 55 | |
| 15 | 1997 | 54 | |
| 16 | 2005 | 51 | |
| 17 | 2003 | 44 | |
| 18 | 2013 | 44 | |
| 19 | 2008 | 43 | |
| 20 | 2015 | 43 |
About Oliver Ebert
Oliver Ebert is a scholar working on Genetics, Hepatology, Immunology, Radiology, Nuclear Medicine and Imaging and Oncology, having authored 48 papers that have together received 1.8k indexed citations. Recurring topics across this work include Virus-based gene therapy research (37 papers), Hepatocellular Carcinoma Treatment and Prognosis (4 papers), RNA Interference and Gene Delivery (2 papers), Immunotherapy and Immune Responses (2 papers), Immune Cell Function and Interaction (2 papers), Nanoparticle-Based Drug Delivery (1 paper), Acute Myeloid Leukemia Research (1 paper) and Pancreatic and Hepatic Oncology Research (1 paper). The work is most often cited by research in Genetics (1.1k citations), Hepatology (214 citations), Immunology (261 citations), Oncology (146 citations) and Biotechnology (29 citations). Oliver Ebert has collaborated with scholars based in Germany, United States and Japan. Frequent co-authors include Savio L.C. Woo, Katsunori Shinozaki, Jennifer Altomonte, Adolfo García‐Sastre, Roland Michael Schmid, Sabrina Marozin, Chryssanthi S. Kournioti, Tiangui Huang, Marcia L. Meseck and John T. Fallon. Their work appears in journals such as Molecular Therapy, Cancer Gene Therapy, Journal of Virology, Journal of Hepatology and Hepatology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.